Corient Private Wealth’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,480
Closed -$3.81M 2891
2025
Q4
$3.81M Buy
37,480
+22,702
+154% +$1.82M ﹤0.01% 1188
2025
Q3
$809K Sell
14,778
-1,761
-11% -$88K ﹤0.01% 1529
2025
Q2
$879K Buy
16,539
+3,550
+27% +$180K ﹤0.01% 1424
2025
Q1
$562K Sell
12,989
-5,824
-31% -$295K ﹤0.01% 1545
2024
Q4
$1.06M Sell
18,813
-13,018
-41% -$810K ﹤0.01% 1298
2024
Q3
$2.17M Sell
31,831
-7,397
-19% -$417K ﹤0.01% 1061
2024
Q2
$1.66M Buy
39,228
+9,659
+33% +$531K ﹤0.01% 1110
2024
Q1
$2.04M Buy
29,569
+733
+3% +$46.4K ﹤0.01% 1012
2023
Q4
$2.13M Buy
28,836
+8,530
+42% +$559K ﹤0.01% 975
2023
Q3
$1.38M Sell
20,306
-1,322
-6% -$112K ﹤0.01% 1063
2023
Q2
$2.03M Buy
21,628
+3,508
+19% +$274K ﹤0.01% 896
2023
Q1
$1.23M Buy
18,120
+3,246
+22% +$209K ﹤0.01% 1012
2022
Q4
$736K Buy
+14,874
New +$608K ﹤0.01% 1011

Other funds holding EXAS

Corient Private Wealth's EXAS Position: Q1 2026 in Review

Corient Private Wealth sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 37,480 shares — an estimated $3.81M sold.

Corient Private Wealth first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $3.81M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Corient Private Wealth reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Corient Private Wealth sold 37,480 Exact Sciences shares in Q1 2026, an estimated $3.81M.
  • Corient Private Wealth first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Corient Private Wealth's Exact Sciences position peaked at $3.81M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.